Sophia Yohe1, Bharat Thyagarajan1. 1. From the Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.
Abstract
CONTEXT: - Next-generation sequencing (NGS) is a technology being used by many laboratories to test for inherited disorders and tumor mutations. This technology is new for many practicing pathologists, who may not be familiar with the uses, methodology, and limitations of NGS. OBJECTIVE: - To familiarize pathologists with several aspects of NGS, including current and expanding uses; methodology including wet bench aspects, bioinformatics, and interpretation; validation and proficiency; limitations; and issues related to the integration of NGS data into patient care. DATA SOURCES: - The review is based on peer-reviewed literature and personal experience using NGS in a clinical setting at a major academic center. CONCLUSIONS: - The clinical applications of NGS will increase as the technology, bioinformatics, and resources evolve to address the limitations and improve quality of results. The challenge for clinical laboratories is to ensure testing is clinically relevant, cost-effective, and can be integrated into clinical care.
CONTEXT: - Next-generation sequencing (NGS) is a technology being used by many laboratories to test for inherited disorders and tumor mutations. This technology is new for many practicing pathologists, who may not be familiar with the uses, methodology, and limitations of NGS. OBJECTIVE: - To familiarize pathologists with several aspects of NGS, including current and expanding uses; methodology including wet bench aspects, bioinformatics, and interpretation; validation and proficiency; limitations; and issues related to the integration of NGS data into patient care. DATA SOURCES: - The review is based on peer-reviewed literature and personal experience using NGS in a clinical setting at a major academic center. CONCLUSIONS: - The clinical applications of NGS will increase as the technology, bioinformatics, and resources evolve to address the limitations and improve quality of results. The challenge for clinical laboratories is to ensure testing is clinically relevant, cost-effective, and can be integrated into clinical care.
Authors: I Borget; J Bonastre; Arnaud Bayle; N Droin; B Besse; Z Zou; Y Boursin; S Rissel; E Solary; L Lacroix; E Rouleau Journal: Eur J Health Econ Date: 2021-03-25
Authors: Nora Chokr; Alexander B Pine; Jan Philipp Bewersdorf; Rory M Shallis; Maximilian Stahl; Amer M Zeidan Journal: Expert Rev Hematol Date: 2019-04-12 Impact factor: 2.929
Authors: Fang Wang; Shaojun Zhang; Tae-Beom Kim; Yu-Yu Lin; Ramiz Iqbal; Zixing Wang; Vakul Mohanty; Kanishka Sircar; Jose A Karam; Michael C Wendl; Funda Meric-Bernstam; John N Weinstein; Li Ding; Gordon B Mills; Ken Chen Journal: Nat Methods Date: 2019-04-15 Impact factor: 28.547